Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Peter Davidson

    TitleAssistant Adjunct Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0507
    CA La Jolla 92093
    Phone415-271-9474
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      OPR mis/use and transitions to heroin and injecting in suburban and exurban Southern California
      CDC/NCIPC U01CE002778Sep 1, 2016 - Aug 31, 2018
      Role: Principal Investigator
      Impacts of a Novel law-enforcement delivered intervention on drug user health
      NIH/NIDA R01DA040648May 1, 2016 - Feb 28, 2021
      Role: Principal Investigator
      Ethical collaborations between substance abuse researchers and community groups
      NIH/NIDA R21DA039782May 1, 2015 - Apr 30, 2017
      Role: Principal Investigator
      A Mixed-Method Study of Injection Drug Use Settings Among FSWs in Tijuana
      NIH/NIDA K01DA032443May 15, 2012 - Apr 30, 2016
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kral AH, Davidson P. Addressing the Nation's Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S. Am J Prev Med. 2017 Aug 04. PMID: 28801014.
        View in: PubMed
      2. Noppert GA, Yang Z, Clarke P, Ye W, Davidson P, Wilson ML. Individual- and neighborhood-level contextual factors are associated with Mycobacterium tuberculosis transmission: genotypic clustering of cases in Michigan, 2004-2012. Ann Epidemiol. 2017 Jun; 27(6):371-376.e5. PMID: 28571914.
        View in: PubMed
      3. Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016; 13(1):25. PMID: 27629248.
        View in: PubMed
      4. Wagner KD, Bovet LJ, Haynes B, Joshua A, Davidson P. Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members. Drug Alcohol Depend. 2016 Aug 1; 165:22-8. PMID: 27262898.
        View in: PubMed
      5. Fielding-Miller R, Davidson P, Raj A. Blacks face higher risk of drug arrests in White neighborhoods. Int J Drug Policy. 2016 Jun; 32:100-3. PMID: 27129793.
        View in: PubMed
      6. Riley ED, Evans JL, Hahn JA, Briceno A, Davidson P, Lum PJ, Page K. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs. Am J Public Health. 2016 May; 106(5):915-7. PMID: 26985620.
        View in: PubMed
      7. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths. J Urban Health. 2016 Feb; 93(1):117-30. PMID: 26800987.
        View in: PubMed
      8. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015 Aug; 110(8):1301-10. PMID: 25917125.
        View in: PubMed
      9. Siddiqui SS, Armenta RF, Evans JL, Yu M, Cuevas-Mota J, Page K, Davidson P, Garfein RS. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA. Int J Drug Policy. 2015 Nov; 26(11):1150-7. PMID: 26252980.
        View in: PubMed
      10. Wheeler E, Jones TS, Gilbert MK, Davidson P. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015 Jun 19; 64(23):631-5. PMID: 26086633.
        View in: PubMed
      11. Wagner KD, Liu L, Davidson P, Cuevas-Mota J, Armenta RF, Garfein RS. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention. Drug Alcohol Depend. 2015 Aug 1; 153:215-20. PMID: 26091751.
        View in: PubMed
      12. Davidson P, Martinez A, Lutnick A, Kral AH, Bluthenthal RN. Drug-related deaths and the sales of needles through pharmacies. Drug Alcohol Depend. 2015 Feb 1; 147:229-34. PMID: 25499730.
        View in: PubMed
      13. Davidson P, Howe M. Beyond NIMBYism: Understanding community antipathy toward needle distribution services. Int J Drug Policy. 2014 May; 25(3):624-32. PMID: 24309432.
        View in: PubMed
      14. Wagner KD, Davidson P, Iverson E, Washburn R, Burke E, Kral AH, McNeeley M, Bloom JJ, Lankenau SE. "I felt like a superhero": The experience of responding to drug overdose among individuals trained in overdose prevention. Int J Drug Policy. 2014 Jan; 25(1):157-65. PMID: 23932166.
        View in: PubMed
      15. Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson P, Page K, Hahn JA. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics. J Urban Health. 2013 Jun; 90(3):500-15. PMID: 22744293.
        View in: PubMed
      16. Wagner KD, Iverson E, Wong CF, Bloom JJ, McNeeley M, Davidson P, McCarty C, Kral AH, Lankenau SE. Personal social network factors associated with overdose prevention training participation. Subst Use Misuse. 2013 Jan; 48(1-2):21-30. PMID: 22988840.
        View in: PubMed
      17. Le Marchand C, Evans J, Page K, Davidson P, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013 Jan 1; 127(1-3):143-9. PMID: 22819868.
        View in: PubMed
      18. Davidson P, Lozada R, Rosen PC, Macias A, Gallardo M, Pollini RA. Negotiating access: social barriers to purchasing syringes at pharmacies in Tijuana, Mexico. Int J Drug Policy. 2012 Jul; 23(4):286-94. PMID: 22676968.
        View in: PubMed
      19. Davidson P, Page K. Research participation as work: comparing the perspectives of researchers and economically marginalized populations. Am J Public Health. 2012 Jul; 102(7):1254-9. PMID: 22594754.
        View in: PubMed
      20. Evans JL, Tsui JI, Hahn JA, Davidson P, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012 Feb 15; 175(4):302-8. PMID: 22227793.
        View in: PubMed
      21. Singh KM, Phung YT, Kohla MS, Lan BY, Chan S, Suen DL, Murad S, Rheault S, Davidson P, Evans J, Singh M, Dohil S, Osorio RW, Wakil AE, Page K, Feng S, Cooper SL. KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies. Immunogenetics. 2012 Feb; 64(2):97-109. PMID: 21898189.
        View in: PubMed
      22. Wagner KD, Davidson P, Pollini RA, Strathdee SA, Washburn R, Palinkas LA. Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations. Int J Drug Policy. 2012 Jan; 23(1):54-61. PMID: 21680168.
        View in: PubMed
      23. Davidson P, Scholar S, Howe M. A GIS-based methodology for improving needle exchange service delivery. Int J Drug Policy. 2011 Mar; 22(2):140-4. PMID: 21112757.
        View in: PubMed
      24. Levy V, Evans JL, Stein ES, Davidson P, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine. 2010 Aug 23; 28(37):5947-51. PMID: 20638453.
        View in: PubMed
      25. Hahn JA, Evans JL, Davidson P, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010 Jul; 105(7):1254-64. PMID: 20491725.
        View in: PubMed
      26. Tsui JI, Vittinghoff E, Hahn JA, Evans JL, Davidson P, Page K. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. Drug Alcohol Depend. 2009 Nov 1; 105(1-2):160-3. PMID: 19647375.
        View in: PubMed
      27. Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008 May; 27(3):286-91. PMID: 18368610.
        View in: PubMed
      28. Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson P, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008 Mar; 15(3):229-36. PMID: 18233994.
        View in: PubMed
      29. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis. 2006 Apr; 33(4):228-34. PMID: 16565643.
        View in: PubMed
      30. Ochoa KC, Davidson P, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005 Dec 12; 80(3):297-302. PMID: 15961257.
        View in: PubMed
      31. Davidson P, McLean RL, Kral AH, Gleghorn AA, Edlin BR, Moss AR. Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J Urban Health. 2003 Jun; 80(2):261-73. PMID: 12791802.
        View in: PubMed
      32. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson P, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003 Mar; 80(1):137-46. PMID: 12612103.
        View in: PubMed
      33. Davidson P, Ochoa KC, Hahn JA, Evans JL, Moss AR. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction. 2002 Dec; 97(12):1511-6. PMID: 12472634.
        View in: PubMed